COVID-19 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global COVID-19 diagnostic market size is expected to reach USD 1.78 Billion in 2034 from USD 13.12 Billion in 2025, growing at a CAGR of -19.88% during 2026-2034.The global COVID-19 diagnostic market expanded rapidly during the pandemic as healthcare systems required fast and accurate testing methods to detect infections. Diagnostic technologies such as PCR tests, antigen tests, and antibody tests became essential tools for monitoring the spread of the virus. Governments and healthcare organizations invested heavily in large-scale testing programs, which significantly boosted the demand for COVID-19 diagnostic solutions across hospitals, laboratories, and testing centers.

One of the major drivers of the market is the need for early and reliable detection of infectious diseases. Rapid diagnostic kits and point-of-care testing have improved the speed of diagnosis, helping healthcare professionals respond quickly to outbreaks. Increased investments in diagnostic infrastructure and biotechnology research have also strengthened the development of advanced testing technologies.

Looking ahead, the COVID-19 diagnostic market is expected to evolve with improved molecular testing platforms and multi-disease diagnostic tools. Lessons learned from the pandemic have encouraged governments to strengthen diagnostic preparedness for future outbreaks. Continued innovation in rapid testing and laboratory automation will likely support sustained growth in the global diagnostics industry.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product & Service

• Instruments
• Reagents & Kits
• Services

By Sample Type

• Nasopharyngeal (NP) swabs
• Oropharyngeal (OP) swabs
• Nasal swabs
• Blood
• Others

By Test Type

• Molecular (PCR) Testing
• Antigen-based Testing
• Antibody (Serology) Testing
• Others

By Mode

• Point-of-Care (PoC)
• Non-Point-of-Care (Non-PoC)

By End-Use

• Laboratories
• Hospitals
• Diagnostic Centers and Clinics
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Hologic Inc., PerkinElmer, Inc., bioMerieux SA, Quidel Corporation, Luminex Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics, Altona Diagnostics GmbH, Veredus Laboratories, 1drop Inc., ADT Biotech Sdn Bhd

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Sample Type
• 5.2. Nasopharyngeal (NP) swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Oropharyngeal (OP) swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Nasal swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Type
• 6.2. Molecular (PCR) Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Antigen-based Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Antibody (Serology) Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY MODE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Mode
• 7.2. Point-of-Care (PoC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Non-Point-of-Care (Non-PoC) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Diagnostic Centers and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product & Service
  • 9.2.2 By Sample Type
  • 9.2.3 By Test Type
  • 9.2.4 By Mode
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product & Service
  • 9.3.2 By Sample Type
  • 9.3.3 By Test Type
  • 9.3.4 By Mode
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product & Service
  • 9.4.2 By Sample Type
  • 9.4.3 By Test Type
  • 9.4.4 By Mode
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product & Service
  • 9.5.2 By Sample Type
  • 9.5.3 By Test Type
  • 9.5.4 By Mode
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product & Service
  • 9.6.2 By Sample Type
  • 9.6.3 By Test Type
  • 9.6.4 By Mode
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL COVID-19 DIAGNOSTIC INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Thermo Fisher ScientificInc
  • 11.2.2 F. Hoffmann-La Roche Ltd
  • 11.2.3 Danaher Corporation
  • 11.2.4 Abbott Laboratories
  • 11.2.5 Hologic Inc
  • 11.2.6 PerkinElmerInc
  • 11.2.7 BioMerieux SA
  • 11.2.8 Quidel Corporation
  • 11.2.9 Luminex Corporation
  • 11.2.10 Laboratory Corporation Of America Holdings
  • 11.2.11 Quest Diagnostics
  • 11.2.12 Altona Diagnostics GmbH
  • 11.2.13 Veredus Laboratories
  • 11.2.14 1drop Inc
  • 11.2.15 ADT Biotech Sdn Bhd